Clinical trials
Autoimmune Diseases trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 9 |
| Recruiting | 5 |
| Terminated | 4 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Human Genome Sciences Inc., a GSK Company | 4 |
| Anthera Pharmaceuticals | 3 |
| Bristol-Myers Squibb | 3 |
| Eli Lilly and Company | 3 |
| GlaxoSmithKline | 3 |
| Viatris Innovation GmbH | 3 |
| AstraZeneca | 2 |
| Human Genome Sciences Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 36 |
| Lupus Erythematosus, Systemic | 22 |
| Immune System Diseases | 15 |
| Connective Tissue Diseases | 10 |
| Arthritis, Rheumatoid | 4 |
| Joint Diseases | 3 |
| Lung Diseases, Interstitial | 3 |
| Rheumatic Diseases | 3 |
| Glomerulonephritis | 2 |
| Kidney Diseases | 2 |
Trials
Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.